Mvelase NR, Mlisana KP. Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin. Lancet Infect Dis. 2022;22(2):156-7.
Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin.
By Content Specialist|2022-06-18T22:00:46+02:00June 18, 2022|2021 Publication, 2021: October to December|Comments Off on Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin.
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not Protection